GeneDx Holdings Corp., a genomics company, provides genetic testing services. It primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services. The company also develops an AI-based platform for NGS analysis, interpretation, and clinical reporting for rare disease, hereditary risk, and cancer testing. The company is headquartered in Stamford, Connecticut. Show more

Location: North Tower, Stamford, CT, 06902, United States | Website: https://www.genedx.com | Industry: Diagnostics & Research | Sector: Healthcare


Market Cap

2.356B

52 Wk Range

$25.32 - $117.75

Previous Close

$86.91

Open

$86.60

Volume

888,452

Day Range

$82.40 - $87.02

Enterprise Value

2.59B

Cash

159.2M

Avg Qtr Burn

-475.3K

Insider Ownership

12.56%

Institutional Own.

-

Qtr Updated

03/31/25


Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & IndicationStage & EventCatalyst Date